Related Experiment Video
Updated: Mar 29, 2026
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Effectiveness of anisodamine for the treatment of critically ill patients with septic shock (ACIdoSIS study): study
Zhongheng Zhang1, Jiancang Zhou1, You Shang1
11 Department of Critical Care Medicine, Jinhua Municipal Central Hospital, Jinhua Hospital of Zhejiang University, Jinhua 321000, China ; 2 Department of Critical Care Medicine, Sir Run Run Shaw hospital, Zhejiang University School of Medicine, Hangzhou 310058, China ; 3 Department of Critical Care Medicine, Union Hospital, Tongji Medical Collegue, Huazhong University of Science and Technology, Wuhan 430022, China ; 4 Department of Critical Care Medicine, Binzhou People's Hospital of Shandong Province, Binzhou 256600, China ; 5 Department of Critical Care Medicine, Peace Hospital of Changzhi Medical College, the First Clinical College, Changzhi 046011, China ; 6 Department of Infection Control and Hospital Epidemiology, the First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China ; 7 Department of Critical Care Medicine, Lishui Municipal Central Hospital, Lishui 323000, China ; 8 Department of Critical Care Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200001, China ; 9 Department of Critical Care Medicine, the First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China.
Background:
Septic shock is an important contributor of mortality in the intensive care unit (ICU). Although strenuous effort has been made to improve its outcome, the mortality rate is only marginally decreased. The present study aimed to investigate the effectiveness of anisodamine in the treatment of septic shock, in the hope that the drug will provide alternatives to the treatment of septic shock.
Methods:
The study is a multi-center randomized controlled clinical trial. Study population will include critically ill patients with septic shock requiring vasopressor use. Blocked randomization was performed where anisodamine and control treatments were allocated at random in a ratio of 1:1 in blocks of sizes 2, 4, 6, 8, and 10 to 354 subjects. Interim analysis will be performed. The primary study end point is the hospital mortality, and other secondary study endpoints include ICU mortality, length of stay in ICU and hospital, organ failure free days. Adverse events including new onset psychosis, urinary retention, significant hypotension and tachycardia will be reported.
Discussion:
The study will provide new insight into the treatment of septic shock and can help to reduce mortality rate of septic shock.
Trial Registration:
NCT02442440 (https://register.clinicaltrials.gov/).
Related Concept Videos
01:30Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
01:24Parenteral Anesthetics: Overview
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence